Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy

Paula Triana-Fonseca,1 Juan Fernando Parada-Márquez,1 Claudia T Silva-Aldana,2 Daniela Zambrano-Arenas,1 Laura Lucia Arias-Gomez,2 Natalia Morales-Fonseca,3 Esteban Medina-Méndez,2 Carlos M Restrepo,4 Daniel Felipe Silgado-Guzmán,2 Dora Janeth Fonseca-Mendoza4 1Facultad de Medicina, Universidad del...

Full description

Bibliographic Details
Main Authors: Triana-Fonseca P, Parada-Márquez JF, Silva-Aldana CT, Zambrano-Arenas D, Arias-Gomez LL, Morales-Fonseca N, Medina-Méndez E, Restrepo CM, Silgado-Guzmán DF, Fonseca-Mendoza DJ
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:The Application of Clinical Genetics
Subjects:
Online Access:https://www.dovepress.com/genetic-profile-of-the-dystrophin-gene-reveals-new-mutations-in-colomb-peer-reviewed-fulltext-article-TACG
_version_ 1818918258587205632
author Triana-Fonseca P
Parada-Márquez JF
Silva-Aldana CT
Zambrano-Arenas D
Arias-Gomez LL
Morales-Fonseca N
Medina-Méndez E
Restrepo CM
Silgado-Guzmán DF
Fonseca-Mendoza DJ
author_facet Triana-Fonseca P
Parada-Márquez JF
Silva-Aldana CT
Zambrano-Arenas D
Arias-Gomez LL
Morales-Fonseca N
Medina-Méndez E
Restrepo CM
Silgado-Guzmán DF
Fonseca-Mendoza DJ
author_sort Triana-Fonseca P
collection DOAJ
description Paula Triana-Fonseca,1 Juan Fernando Parada-Márquez,1 Claudia T Silva-Aldana,2 Daniela Zambrano-Arenas,1 Laura Lucia Arias-Gomez,2 Natalia Morales-Fonseca,3 Esteban Medina-Méndez,2 Carlos M Restrepo,4 Daniel Felipe Silgado-Guzmán,2 Dora Janeth Fonseca-Mendoza4 1Facultad de Medicina, Universidad del Bosque, Bogotá, DC, Colombia; 2Department of Molecular Diagnosis, Genética Molecular de Colombia SAS, Bogotá, DC, Colombia; 3Department of Medicine, Instituto Colombiano de Neurociencias, Bogotá, DC, Colombia; 4Center for Research in Genetics and Genomics – CIGGUR, GENIUROS Research Group, School of Medicine and Health Sciences, Universidad Del Rosario, Bogotá, DC, ColombiaCorrespondence: Dora Janeth Fonseca-Mendoza; Daniel Felipe Silgado Guzmán Email dora.fonseca@urosario.edu.co; dansilgado@hotmail.comBackground: Duchenne and Becker muscular dystrophies (DMD/BMD) are the most common human dystrophinopathies with recessive X-linked inheritance. Dystrophin gene deletions and duplications are the most common mutations, followed by point mutations. The aim of this study is to characterize the mutational profile of the dystrophin gene in Colombian patients with DMD/BMD.Material and Methods: Mutational profiling was determined in 69 affected patients using Sanger sequencing, next-generation sequencing (NGS) and/or multiplex ligation dependent-probes amplification (MLPA). Genetic variants were classified according to molecular consequence and new variants were determined through database and literature analysis.Results: Mutational profile in affected patients revealed that large deletions/duplications analyzed by MLPA accounted for 72.5% of all genetic variations. By using Sanger sequencing or NGS, we identified point mutations in 15.9% and small deletions in 11.6% of the patients. New mutations were found, most of them were point mutations or small deletions (10.1%).Conclusion: Our results described the genetic profile of the dystrophin gene in Colombian patients with DMD and contribute to efforts to identify molecular variants in Latin American populations. For our population, 18.8% of cases could be treated with FDA or MDA approved molecular therapies based on specific mutations. These data contribute to the establishment of appropriate genetic counseling and potential treatment.Keywords: Duchenne–Becker muscular dystrophy, DMD, MLPA, next-generation sequencing, target molecular therapy, exon skipping, mutation
first_indexed 2024-12-20T00:47:06Z
format Article
id doaj.art-4b938f09672441be890801d51e15d04e
institution Directory Open Access Journal
issn 1178-704X
language English
last_indexed 2024-12-20T00:47:06Z
publishDate 2021-10-01
publisher Dove Medical Press
record_format Article
series The Application of Clinical Genetics
spelling doaj.art-4b938f09672441be890801d51e15d04e2022-12-21T19:59:22ZengDove Medical PressThe Application of Clinical Genetics1178-704X2021-10-01Volume 1439940869334Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular DystrophinopathyTriana-Fonseca PParada-Márquez JFSilva-Aldana CTZambrano-Arenas DArias-Gomez LLMorales-Fonseca NMedina-Méndez ERestrepo CMSilgado-Guzmán DFFonseca-Mendoza DJPaula Triana-Fonseca,1 Juan Fernando Parada-Márquez,1 Claudia T Silva-Aldana,2 Daniela Zambrano-Arenas,1 Laura Lucia Arias-Gomez,2 Natalia Morales-Fonseca,3 Esteban Medina-Méndez,2 Carlos M Restrepo,4 Daniel Felipe Silgado-Guzmán,2 Dora Janeth Fonseca-Mendoza4 1Facultad de Medicina, Universidad del Bosque, Bogotá, DC, Colombia; 2Department of Molecular Diagnosis, Genética Molecular de Colombia SAS, Bogotá, DC, Colombia; 3Department of Medicine, Instituto Colombiano de Neurociencias, Bogotá, DC, Colombia; 4Center for Research in Genetics and Genomics – CIGGUR, GENIUROS Research Group, School of Medicine and Health Sciences, Universidad Del Rosario, Bogotá, DC, ColombiaCorrespondence: Dora Janeth Fonseca-Mendoza; Daniel Felipe Silgado Guzmán Email dora.fonseca@urosario.edu.co; dansilgado@hotmail.comBackground: Duchenne and Becker muscular dystrophies (DMD/BMD) are the most common human dystrophinopathies with recessive X-linked inheritance. Dystrophin gene deletions and duplications are the most common mutations, followed by point mutations. The aim of this study is to characterize the mutational profile of the dystrophin gene in Colombian patients with DMD/BMD.Material and Methods: Mutational profiling was determined in 69 affected patients using Sanger sequencing, next-generation sequencing (NGS) and/or multiplex ligation dependent-probes amplification (MLPA). Genetic variants were classified according to molecular consequence and new variants were determined through database and literature analysis.Results: Mutational profile in affected patients revealed that large deletions/duplications analyzed by MLPA accounted for 72.5% of all genetic variations. By using Sanger sequencing or NGS, we identified point mutations in 15.9% and small deletions in 11.6% of the patients. New mutations were found, most of them were point mutations or small deletions (10.1%).Conclusion: Our results described the genetic profile of the dystrophin gene in Colombian patients with DMD and contribute to efforts to identify molecular variants in Latin American populations. For our population, 18.8% of cases could be treated with FDA or MDA approved molecular therapies based on specific mutations. These data contribute to the establishment of appropriate genetic counseling and potential treatment.Keywords: Duchenne–Becker muscular dystrophy, DMD, MLPA, next-generation sequencing, target molecular therapy, exon skipping, mutationhttps://www.dovepress.com/genetic-profile-of-the-dystrophin-gene-reveals-new-mutations-in-colomb-peer-reviewed-fulltext-article-TACGduchenne-becker muscular dystrophydmdmlpanext-generation sequencingtarget molecular therapyexon skippingmutation
spellingShingle Triana-Fonseca P
Parada-Márquez JF
Silva-Aldana CT
Zambrano-Arenas D
Arias-Gomez LL
Morales-Fonseca N
Medina-Méndez E
Restrepo CM
Silgado-Guzmán DF
Fonseca-Mendoza DJ
Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy
The Application of Clinical Genetics
duchenne-becker muscular dystrophy
dmd
mlpa
next-generation sequencing
target molecular therapy
exon skipping
mutation
title Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy
title_full Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy
title_fullStr Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy
title_full_unstemmed Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy
title_short Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy
title_sort genetic profile of the dystrophin gene reveals new mutations in colombian patients affected with muscular dystrophinopathy
topic duchenne-becker muscular dystrophy
dmd
mlpa
next-generation sequencing
target molecular therapy
exon skipping
mutation
url https://www.dovepress.com/genetic-profile-of-the-dystrophin-gene-reveals-new-mutations-in-colomb-peer-reviewed-fulltext-article-TACG
work_keys_str_mv AT trianafonsecap geneticprofileofthedystrophingenerevealsnewmutationsincolombianpatientsaffectedwithmusculardystrophinopathy
AT paradamarquezjf geneticprofileofthedystrophingenerevealsnewmutationsincolombianpatientsaffectedwithmusculardystrophinopathy
AT silvaaldanact geneticprofileofthedystrophingenerevealsnewmutationsincolombianpatientsaffectedwithmusculardystrophinopathy
AT zambranoarenasd geneticprofileofthedystrophingenerevealsnewmutationsincolombianpatientsaffectedwithmusculardystrophinopathy
AT ariasgomezll geneticprofileofthedystrophingenerevealsnewmutationsincolombianpatientsaffectedwithmusculardystrophinopathy
AT moralesfonsecan geneticprofileofthedystrophingenerevealsnewmutationsincolombianpatientsaffectedwithmusculardystrophinopathy
AT medinamendeze geneticprofileofthedystrophingenerevealsnewmutationsincolombianpatientsaffectedwithmusculardystrophinopathy
AT restrepocm geneticprofileofthedystrophingenerevealsnewmutationsincolombianpatientsaffectedwithmusculardystrophinopathy
AT silgadoguzmandf geneticprofileofthedystrophingenerevealsnewmutationsincolombianpatientsaffectedwithmusculardystrophinopathy
AT fonsecamendozadj geneticprofileofthedystrophingenerevealsnewmutationsincolombianpatientsaffectedwithmusculardystrophinopathy